Gaviscon Liquid - Peppermint Flavour *

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14 September 2021

File name

Gaviscon Liquid Peppermint Flavour PIL_1631635919.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 18 June 2021

File name

Gaviscon Liquid Peppermint Flavour_1624015921.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.9 - Overdose

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Addition of information regarding sodium content.

Rewording of Sect 4.9

Updated on 15 January 2020

File name

Gaviscon Liquid Peppermint_1579097555.pdf

Reasons for updating

  • New PIL for new product

Updated on 02 September 2014

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale

Updated on 02 September 2014

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.2 - added information for special patient groups
Section 4.3 - added contraindications for hypersensitivity to the active substances or excipients
Section 4.4 - Added additional precautions
Section 4.5 - added a time interval between taking Gaviscon and other medicinal products
Section 4.6 - Change to the format of section and an update to the information for taking Gaviscon during pregnancy
Section 4.7 -  Editorial change
Section 4.8 - Update to layout of frequency of adverse events and addition of reporting of adverse reactions
Section 5.1 - addition of ATC code and pharacotherapeutic group
Section 10 - updated date of revision of the text

Updated on 02 September 2014

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

Section 4.2 - added information for special patient groups
Section 4.3 - added contraindications for hypersensitivity to the active substances or excipients
Section 4.4 - Added additional precautions
Section 4.5 - added a time interval between taking Gaviscon and other medicinal products
Section 4.6 - Change to the format of section and an update to the information for taking Gaviscon during pregnancy
Section 4.7 -  Editorial change
Section 4.8 - Update to layout of frequency of adverse events and addition of reporting of adverse reactions
Section 5.1 - addition of ATC code and pharacotherapeutic group
Section 10 - updated date of revision of the text

Updated on 13 December 2012

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

In section 4.4, added " Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions."

Updated on 13 December 2012

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Free text change information supplied by the pharmaceutical company

In section 4.4, added " Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions."

Updated on 10 December 2012

Reasons for updating

  • Change to section 6.4 - Special precautions for storage
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

In section 6.4, "do not refrigerate" has been added.
In section 10, the date of revision of the text has been updated to November 2012.

Updated on 10 December 2012

Reasons for updating

  • Change to section 6.4 - Special precautions for storage
  • Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

In section 6.4, "do not refrigerate" has been added.
In section 10, the date of revision of the text has been updated to November 2012.

Updated on 15 May 2007

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.8.  Allergic manifestations expanded to include anaphylactic and anaphylactoid reactions.
 
Section 7.  Change of marketing authorisation holder address to: 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Updated on 15 May 2007

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Free text change information supplied by the pharmaceutical company

Section 4.8.  Allergic manifestations expanded to include anaphylactic and anaphylactoid reactions.
 
Section 7.  Change of marketing authorisation holder address to: 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Updated on 09 August 2006

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 6.3 - Shelf life
  • Change to section 6.5 - Nature and contents of container

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Changes to pack sizes in sections 4.1, 4.2, 4.4 and 6.5.  Pack sizes of 200 and 300ml have been removed from the sections denoting packs for retail sale through pharmacies only and a 300 ml pack has been added to the sections denoting packs for general sale.

Reduction in shelf-life from three years to two years in section 6.3

Updated on 09 August 2006

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 6.3 - Shelf life
  • Change to section 6.5 - Nature and contents of container

Free text change information supplied by the pharmaceutical company

Changes to pack sizes in sections 4.1, 4.2, 4.4 and 6.5.  Pack sizes of 200 and 300ml have been removed from the sections denoting packs for retail sale through pharmacies only and a 300 ml pack has been added to the sections denoting packs for general sale.

Reduction in shelf-life from three years to two years in section 6.3

Updated on 01 July 2005

Reasons for updating

  • Change to section 4.2 - Posology and method of administration

Updated on 01 July 2005

Reasons for updating

  • Change to section 4.2 - Posology and method of administration

Legal category:Supply through general sale

Updated on 19 May 2005

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through general sale

Updated on 19 May 2005

Reasons for updating

  • Improved electronic presentation

Updated on 10 August 2004

Reasons for updating

  • New SPC for medicines.ie

Legal category:Supply through general sale

Updated on 10 August 2004

Reasons for updating

  • New SPC for medicines.ie